Bill · H.Res. 803· House(119-HRES-803)

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Age: 61 years

Tennessee

Introduced: 10/10/2025
Last activity: 10/10/2025 — Referred to the House Committee on Energy and Commerce.
Sponsored by: John Rose
Cosponsors: - 11 - 0

Health

Introduced
In Committee

A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.

What this bill would do

This resolution urges the Director of the Food and Drug Administration to perform a reevaluation of the safety of all chemical abortion drugs. It cites independent studies suggesting that these drugs may have a higher rate of serious complications than what is currently reported. The resolution also calls for the public release of a full safety review that includes real-world outcomes and complications. It highlights concerns regarding expanded access to these drugs through previous administration actions.

Yes

Does this make what the government does easier for the public to see?+5
The resolution calls for the public release of a full safety review including real-world outcomes and complications.

The opposite

Does this make abortion easier to get?-5
The resolution seeks to reevaluate the safety of chemical abortion drugs, which could lead to increased regulatory hurdles and reduced access.
Would women be better off under this?-3
The text cites concerns regarding potential physical and emotional harm to women caused by expanded access to chemical abortion drugs.
Does this narrow the gap between how men and women are treated?-3
The bill identifies potential physical and emotional harm to women and girls resulting from current access levels.